
Wen Huang
Examiner (ID: 19338, Phone: (571)270-0234 , Office: P/2872 )
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872 |
| Total Applications | 956 |
| Issued Applications | 765 |
| Pending Applications | 100 |
| Abandoned Applications | 114 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17830119
[patent_doc_number] => 20220267423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => IGE ANTIBODIES CROSS-REACTIVE TO ALLERGENS AND TUMOR ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/391314
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391314 | IGE ANTIBODIES CROSS-REACTIVE TO ALLERGENS AND TUMOR ANTIGENS | Aug 1, 2021 | Abandoned |
Array
(
[id] => 19381230
[patent_doc_number] => 20240271100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/018787
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -160
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018787 | IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS | Jul 29, 2021 | Pending |
Array
(
[id] => 17533851
[patent_doc_number] => 20220112460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => NANOCOIL-SUBSTRATE COMPLEX FOR CONTROLLING STEM CELL BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELL BY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/443501
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443501 | NANOCOIL-SUBSTRATE COMPLEX FOR CONTROLLING STEM CELL BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELL BY USING THE SAME | Jul 26, 2021 | Abandoned |
Array
(
[id] => 18164788
[patent_doc_number] => 20230031385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => STORAGE MEDIA FOR PRESERVATION OF CORNEAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/380474
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/380474 | STORAGE MEDIA FOR PRESERVATION OF CORNEAL TISSUE | Jul 19, 2021 | Abandoned |
Array
(
[id] => 19352562
[patent_doc_number] => 12052986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Portable oxygen source with perfusion system
[patent_app_type] => utility
[patent_app_number] => 17/305472
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5307
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305472 | Portable oxygen source with perfusion system | Jul 7, 2021 | Issued |
Array
(
[id] => 17532271
[patent_doc_number] => 20220110880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => NANOHELIX-SUBSTRATE COMPLEX FOR CONTROLLING MACROPHAGE BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND POLARIZATION OF MACROPAGE BY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/368883
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368883 | Nanohelix-substrate complex for controlling macrophage behavior, preparation method thereof, and method of controlling adhesion and polarization of macrophage by using the same | Jul 6, 2021 | Issued |
Array
(
[id] => 17333764
[patent_doc_number] => 20220000095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ERYTHROCYTE MEMBRANE COATING
[patent_app_type] => utility
[patent_app_number] => 17/366187
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366187 | ERYTHROCYTE MEMBRANE COATING | Jul 1, 2021 | Abandoned |
Array
(
[id] => 18567354
[patent_doc_number] => 20230257686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR PRODUCING CARTILAGE TISSUE
[patent_app_type] => utility
[patent_app_number] => 18/003737
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003737
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003737 | METHOD FOR PRODUCING CARTILAGE TISSUE | Jun 30, 2021 | Abandoned |
Array
(
[id] => 18709562
[patent_doc_number] => 20230332182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA
[patent_app_type] => utility
[patent_app_number] => 18/004151
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -155
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004151
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004151 | COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA | Jun 30, 2021 | Pending |
Array
(
[id] => 17314897
[patent_doc_number] => 20210403945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS
[patent_app_type] => utility
[patent_app_number] => 17/356920
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356920 | COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS | Jun 23, 2021 | Abandoned |
Array
(
[id] => 17297697
[patent_doc_number] => 20210393536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/355290
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355290 | METHODS AND COMPOSITIONS RELATED TO EXTRACELLULAR VESICLES | Jun 22, 2021 | Pending |
Array
(
[id] => 18673033
[patent_doc_number] => 20230310505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/006684
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006684 | COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT | Jun 20, 2021 | Pending |
Array
(
[id] => 18485182
[patent_doc_number] => 20230212509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/000008
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -151
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000008 | BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF | May 27, 2021 | Pending |
Array
(
[id] => 18449544
[patent_doc_number] => 20230190820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CELL HARVEST METHOD
[patent_app_type] => utility
[patent_app_number] => 17/927415
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927415 | CELL HARVEST METHOD | May 26, 2021 | Abandoned |
Array
(
[id] => 18511617
[patent_doc_number] => 20230227787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => MASS PRODUCTION METHOD OF UNIFORM SIZE CELL AGGREGATES
[patent_app_type] => utility
[patent_app_number] => 17/926971
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926971 | MASS PRODUCTION METHOD OF UNIFORM SIZE CELL AGGREGATES | May 26, 2021 | Pending |
Array
(
[id] => 18436017
[patent_doc_number] => 20230183311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/926374
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926374 | POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY | May 25, 2021 | Pending |
Array
(
[id] => 17228885
[patent_doc_number] => 20210355441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS
[patent_app_type] => utility
[patent_app_number] => 17/323715
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323715 | GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS | May 17, 2021 | Pending |
Array
(
[id] => 17355395
[patent_doc_number] => 20220016191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => SIMULTANEOUS DELIVERY OF CANCER TREATMENT PROGRAMS TO TUMOR AND IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/320965
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320965 | SIMULTANEOUS DELIVERY OF CANCER TREATMENT PROGRAMS TO TUMOR AND IMMUNE CELLS | May 13, 2021 | Abandoned |
Array
(
[id] => 18583132
[patent_doc_number] => 20230265391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/924040
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924040 | METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS | May 6, 2021 | Pending |
Array
(
[id] => 17214576
[patent_doc_number] => 20210347913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH
[patent_app_type] => utility
[patent_app_number] => 17/313121
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313121 | Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such | May 5, 2021 | Issued |